Rank | Gene Set | Z-score |
---|---|---|
1 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.00113012 |
2 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.44493957 |
3 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.37699469 |
4 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.37699469 |
5 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.26722237 |
6 | neutrophil activation involved in immune response (GO:0002283) | 4.23219585 |
7 | * positive regulation of interferon-alpha production (GO:0032727) | 4.22506269 |
8 | response to type I interferon (GO:0034340) | 4.19606235 |
9 | type I interferon signaling pathway (GO:0060337) | 4.17266215 |
10 | cellular response to type I interferon (GO:0071357) | 4.17266215 |
11 | negative regulation of cell killing (GO:0031342) | 4.02415687 |
12 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.02415687 |
13 | * regulation of interferon-alpha production (GO:0032647) | 4.00497348 |
14 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.86812404 |
15 | immunoglobulin mediated immune response (GO:0016064) | 3.85632421 |
16 | response to interleukin-15 (GO:0070672) | 3.71509386 |
17 | tolerance induction (GO:0002507) | 3.67950379 |
18 | response to peptidoglycan (GO:0032494) | 3.65624442 |
19 | cellular response to interferon-beta (GO:0035458) | 3.56833409 |
20 | cellular response to interleukin-15 (GO:0071350) | 3.54637928 |
21 | positive regulation of natural killer cell differentiation (GO:0032825) | 3.53695443 |
22 | myeloid dendritic cell activation (GO:0001773) | 3.45923920 |
23 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.43161726 |
24 | negative regulation of T cell mediated immunity (GO:0002710) | 3.42308545 |
25 | neutrophil activation (GO:0042119) | 3.39363056 |
26 | negative regulation of interleukin-12 production (GO:0032695) | 3.37380321 |
27 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.37291606 |
28 | granulocyte activation (GO:0036230) | 3.36561718 |
29 | myeloid dendritic cell differentiation (GO:0043011) | 3.36430138 |
30 | response to muramyl dipeptide (GO:0032495) | 3.36040102 |
31 | interferon-gamma production (GO:0032609) | 3.34875094 |
32 | cellular response to virus (GO:0098586) | 3.34822074 |
33 | regulation of regulatory T cell differentiation (GO:0045589) | 3.34012592 |
34 | response to interferon-beta (GO:0035456) | 3.33575357 |
35 | T cell migration (GO:0072678) | 3.33003848 |
36 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.31699948 |
37 | response to interferon-alpha (GO:0035455) | 3.29922660 |
38 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 3.27702626 |
39 | NIK/NF-kappaB signaling (GO:0038061) | 3.23815873 |
40 | positive T cell selection (GO:0043368) | 3.22639740 |
41 | natural killer cell mediated cytotoxicity (GO:0042267) | 3.21941443 |
42 | natural killer cell mediated immunity (GO:0002228) | 3.21941443 |
43 | positive regulation of granulocyte differentiation (GO:0030854) | 3.21635327 |
44 | cellular response to exogenous dsRNA (GO:0071360) | 3.20385264 |
45 | positive regulation of antigen processing and presentation (GO:0002579) | 3.19809069 |
46 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.19743422 |
47 | * negative regulation of viral genome replication (GO:0045071) | 3.18561305 |
48 | B cell mediated immunity (GO:0019724) | 3.18149026 |
49 | defense response to protozoan (GO:0042832) | 3.16710690 |
50 | negative thymic T cell selection (GO:0045060) | 3.16402276 |
51 | negative regulation of T-helper cell differentiation (GO:0045623) | 3.15782834 |
52 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 3.15782834 |
53 | negative T cell selection (GO:0043383) | 3.14328585 |
54 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.13221121 |
55 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.13221121 |
56 | modulation by symbiont of host immune response (GO:0052553) | 3.13221121 |
57 | positive regulation by symbiont of host defense response (GO:0052509) | 3.13221121 |
58 | modulation by symbiont of host defense response (GO:0052031) | 3.13221121 |
59 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.13221121 |
60 | positive thymic T cell selection (GO:0045059) | 3.12764058 |
61 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 3.11929537 |
62 | positive regulation of interleukin-12 production (GO:0032735) | 3.10683095 |
63 | cellular response to zinc ion (GO:0071294) | 3.10116478 |
64 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.09068343 |
65 | * positive regulation of interferon-beta production (GO:0032728) | 3.08352772 |
66 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.07564465 |
67 | activated T cell proliferation (GO:0050798) | 3.07463772 |
68 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.05582779 |
69 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.05104453 |
70 | hepatocyte apoptotic process (GO:0097284) | 3.04694830 |
71 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.04136046 |
72 | necroptotic process (GO:0070266) | 3.03843730 |
73 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.02663227 |
74 | regulation of gamma-delta T cell activation (GO:0046643) | 3.02469140 |
75 | T cell selection (GO:0045058) | 3.01824594 |
76 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.01390078 |
77 | response to protozoan (GO:0001562) | 3.00009889 |
78 | respiratory burst (GO:0045730) | 2.98714633 |
79 | positive regulation of interleukin-2 production (GO:0032743) | 2.98561008 |
80 | leukocyte aggregation (GO:0070486) | 2.98486754 |
81 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.94072169 |
82 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.93960074 |
83 | positive regulation of isotype switching (GO:0045830) | 2.93866471 |
84 | regulation of chronic inflammatory response (GO:0002676) | 2.90354440 |
85 | macrophage activation involved in immune response (GO:0002281) | 2.87739999 |
86 | DNA deamination (GO:0045006) | 2.86320309 |
87 | regulation of activation of Janus kinase activity (GO:0010533) | 2.85861240 |
88 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.84404384 |
89 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.83854299 |
90 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.83701277 |
91 | positive regulation of B cell differentiation (GO:0045579) | 2.81517788 |
92 | natural killer cell activation (GO:0030101) | 2.81298175 |
93 | * regulation of interferon-beta production (GO:0032648) | 2.81179344 |
94 | regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370) | 2.80632584 |
95 | alpha-beta T cell differentiation (GO:0046632) | 2.80312667 |
96 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.79918996 |
97 | thymic T cell selection (GO:0045061) | 2.79331872 |
98 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.78573788 |
99 | regulation of antigen processing and presentation (GO:0002577) | 2.78329043 |
100 | regulation of response to interferon-gamma (GO:0060330) | 2.78011785 |
101 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 2.77836314 |
102 | positive regulation of B cell mediated immunity (GO:0002714) | 2.77836314 |
103 | regulation of CD4-positive, alpha-beta T cell activation (GO:2000514) | 2.77424111 |
104 | positive regulation of humoral immune response (GO:0002922) | 2.76063797 |
105 | negative regulation of B cell proliferation (GO:0030889) | 2.75943804 |
106 | alpha-beta T cell activation (GO:0046631) | 2.73716883 |
107 | programmed necrotic cell death (GO:0097300) | 2.73533508 |
108 | positive regulation of cytokine biosynthetic process (GO:0042108) | 2.73257310 |
109 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.71497817 |
110 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.71318865 |
111 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.71318865 |
112 | mast cell activation (GO:0045576) | 2.71282827 |
113 | regulation of alpha-beta T cell activation (GO:0046634) | 2.70845648 |
114 | positive regulation of DNA recombination (GO:0045911) | 2.70172070 |
115 | regulation of hypersensitivity (GO:0002883) | 2.69552125 |
116 | interferon-gamma secretion (GO:0072643) | 2.69489521 |
117 | T cell lineage commitment (GO:0002360) | 2.69215971 |
118 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.69136875 |
119 | regulation of B cell differentiation (GO:0045577) | 2.68424821 |
120 | reactive oxygen species biosynthetic process (GO:1903409) | 2.67801351 |
121 | dendritic cell differentiation (GO:0097028) | 2.67765082 |
122 | positive regulation of defense response to virus by host (GO:0002230) | 2.67691041 |
123 | * regulation of viral genome replication (GO:0045069) | 2.66923913 |
124 | * defense response to virus (GO:0051607) | 2.66206334 |
125 | T cell activation involved in immune response (GO:0002286) | 2.65134081 |
126 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.63803288 |
127 | myeloid cell activation involved in immune response (GO:0002275) | 2.63662080 |
128 | monocyte chemotaxis (GO:0002548) | 2.63268734 |
129 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.63063160 |
130 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.62919842 |
131 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.62842465 |
132 | T-helper 1 type immune response (GO:0042088) | 2.62632434 |
133 | superoxide anion generation (GO:0042554) | 2.62447692 |
134 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 2.62323678 |
135 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.62215874 |
136 | regulation of T cell tolerance induction (GO:0002664) | 2.62082302 |
137 | dendritic cell chemotaxis (GO:0002407) | 2.62062549 |
138 | myeloid leukocyte activation (GO:0002274) | 2.61700257 |
139 | negative regulation of type I interferon production (GO:0032480) | 2.61266593 |
140 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.61011824 |
141 | positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516) | 2.60367695 |
142 | regulation of T cell receptor signaling pathway (GO:0050856) | 2.60202761 |
143 | positive regulation of macrophage differentiation (GO:0045651) | 2.60165950 |
144 | cellular response to interferon-gamma (GO:0071346) | 2.59985798 |
145 | regulation of interleukin-12 production (GO:0032655) | 2.59897316 |
146 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.59728425 |
147 | microglial cell activation (GO:0001774) | 2.59396288 |
148 | T-helper cell differentiation (GO:0042093) | 2.58957231 |
Rank | Gene Set | Z-score |
---|---|---|
1 | * IRF8_22096565_ChIP-ChIP_GC-B_Human | 6.82111594 |
2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 5.32177749 |
3 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 5.20770655 |
4 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.78232336 |
5 | * IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 4.54870029 |
6 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 4.33820749 |
7 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.74928434 |
8 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.65617318 |
9 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.23681349 |
10 | * STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 3.15616098 |
11 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.08913285 |
12 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.07258693 |
13 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.04423247 |
14 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.92537409 |
15 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.87236437 |
16 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.84457563 |
17 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.71086104 |
18 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.58863775 |
19 | MYB_26560356_Chip-Seq_TH2_Human | 2.27133148 |
20 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.24628791 |
21 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.23293543 |
22 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.09738345 |
23 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.08790935 |
24 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.05470974 |
25 | MYB_26560356_Chip-Seq_TH1_Human | 1.95576762 |
26 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.94835531 |
27 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.94265017 |
28 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.87364890 |
29 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.87332667 |
30 | * MAF_26560356_Chip-Seq_TH1_Human | 1.85918129 |
31 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.80645189 |
32 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.79069874 |
33 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.76006288 |
34 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.74088765 |
35 | GATA1_22025678_ChIP-Seq_K562_Human | 1.65589978 |
36 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.59974013 |
37 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.59496962 |
38 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.58551475 |
39 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.58398755 |
40 | * VDR_24763502_ChIP-Seq_THP-1_Human | 1.57326708 |
41 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.57182832 |
42 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.55718381 |
43 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.43314197 |
44 | MYC_22102868_ChIP-Seq_BL_Human | 1.33917860 |
45 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.32962144 |
46 | * UTX_26944678_Chip-Seq_JUKART_Human | 1.32599846 |
47 | * VDR_21846776_ChIP-Seq_THP-1_Human | 1.30962326 |
48 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.30170318 |
49 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.28677111 |
50 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.28411968 |
51 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.27646069 |
52 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.24286143 |
53 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.23219451 |
54 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.19431263 |
55 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.18581894 |
56 | GATA3_26560356_Chip-Seq_TH2_Human | 1.17375550 |
57 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.15905103 |
58 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.15812130 |
59 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.15807480 |
60 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.13607363 |
61 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.12489220 |
62 | MAF_26560356_Chip-Seq_TH2_Human | 1.09483734 |
63 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.07626214 |
64 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.07393232 |
65 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.06948147 |
66 | * SPI1_23127762_ChIP-Seq_K562_Human | 1.05063698 |
67 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.04083736 |
68 | * CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.03832515 |
69 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.02123924 |
70 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.01814583 |
71 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.01166196 |
72 | * GATA1_19941826_ChIP-Seq_K562_Human | 1.00792692 |
73 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.99990431 |
74 | * CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.99866467 |
75 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.99826476 |
76 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.99391442 |
77 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.98829094 |
78 | * PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.98006173 |
79 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.95752089 |
80 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.95469110 |
81 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.95177323 |
82 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.95043520 |
83 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.94707199 |
84 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.94036844 |
85 | FOXP3_21729870_ChIP-Seq_TREG_Human | 0.93734470 |
86 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.92694659 |
87 | GATA3_26560356_Chip-Seq_TH1_Human | 0.92467930 |
88 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.92066663 |
89 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.91732901 |
90 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.91231359 |
91 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.91231359 |
92 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.86207790 |
93 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.85770355 |
94 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.85705916 |
95 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 0.84853163 |
96 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.84465737 |
97 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.84004588 |
98 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.83564072 |
99 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.83250966 |
100 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.81882072 |
101 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.80905274 |
102 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.77851869 |
103 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.76432183 |
104 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.76380967 |
105 | VDR_23849224_ChIP-Seq_CD4+_Human | 0.74475753 |
106 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.74389709 |
107 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.74083922 |
108 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.73721984 |
109 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.72926174 |
110 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.72848376 |
111 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.72531879 |
112 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 0.72237972 |
113 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.71185618 |
114 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.70553110 |
115 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.69998010 |
116 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.69607782 |
117 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.68923525 |
118 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.68820878 |
119 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.68125062 |
120 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.67505297 |
121 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.65266661 |
122 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 0.64053462 |
123 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.62184452 |
124 | * GATA2_19941826_ChIP-Seq_K562_Human | 0.60560896 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0001835_abnormal_antigen_presentation | 4.48210152 |
2 | MP0009785_altered_susceptibility_to | 3.55821496 |
3 | MP0002148_abnormal_hypersensitivity_rea | 3.33350883 |
4 | MP0005671_abnormal_response_to | 3.23224472 |
5 | MP0003436_decreased_susceptibility_to | 3.18137414 |
6 | MP0000685_abnormal_immune_system | 3.10767828 |
7 | MP0005000_abnormal_immune_tolerance | 2.96984651 |
8 | MP0003724_increased_susceptibility_to | 2.93286554 |
9 | MP0005387_immune_system_phenotype | 2.92584534 |
10 | MP0001790_abnormal_immune_system | 2.92584534 |
11 | MP0005025_abnormal_response_to | 2.74564851 |
12 | MP0001800_abnormal_humoral_immune | 2.66305108 |
13 | MP0002419_abnormal_innate_immunity | 2.58684336 |
14 | MP0002452_abnormal_antigen_presenting | 2.57938425 |
15 | MP0002723_abnormal_immune_serum | 2.50863582 |
16 | MP0003763_abnormal_thymus_physiology | 2.43755928 |
17 | MP0006082_CNS_inflammation | 2.41836999 |
18 | MP0001819_abnormal_immune_cell | 2.33565966 |
19 | MP0002420_abnormal_adaptive_immunity | 2.31231692 |
20 | MP0002006_tumorigenesis | 2.28791611 |
21 | MP0002166_altered_tumor_susceptibility | 2.24032718 |
22 | MP0009333_abnormal_splenocyte_physiolog | 2.07920116 |
23 | MP0002405_respiratory_system_inflammati | 2.05083469 |
24 | MP0001853_heart_inflammation | 1.99387995 |
25 | MP0002398_abnormal_bone_marrow | 1.96954223 |
26 | MP0010155_abnormal_intestine_physiology | 1.92890679 |
27 | MP0005464_abnormal_platelet_physiology | 1.89149148 |
28 | MP0000716_abnormal_immune_system | 1.86776285 |
29 | MP0004947_skin_inflammation | 1.75770331 |
30 | MP0001845_abnormal_inflammatory_respons | 1.75469119 |
31 | MP0003303_peritoneal_inflammation | 1.73886682 |
32 | MP0001348_abnormal_lacrimal_gland | 1.68528215 |
33 | MP0004510_myositis | 1.67221108 |
34 | MP0000689_abnormal_spleen_morphology | 1.65279241 |
35 | MP0002722_abnormal_immune_system | 1.59047287 |
36 | MP0001533_abnormal_skeleton_physiology | 1.58985782 |
37 | MP0009764_decreased_sensitivity_to | 1.58072077 |
38 | MP0005397_hematopoietic_system_phenotyp | 1.55874699 |
39 | MP0001545_abnormal_hematopoietic_system | 1.55874699 |
40 | MP0002429_abnormal_blood_cell | 1.53101389 |
41 | MP0003195_calcinosis | 1.51930196 |
42 | MP0005310_abnormal_salivary_gland | 1.49047293 |
43 | MP0008469_abnormal_protein_level | 1.47191764 |
44 | MP0000858_altered_metastatic_potential | 1.44403456 |
45 | MP0003448_altered_tumor_morphology | 1.43265147 |
46 | MP0002138_abnormal_hepatobiliary_system | 1.37540449 |
47 | MP0002396_abnormal_hematopoietic_system | 1.35771659 |
48 | MP0004808_abnormal_hematopoietic_stem | 1.31993717 |
49 | MP0004782_abnormal_surfactant_physiolog | 1.31385894 |
50 | MP0002009_preneoplasia | 1.29315314 |
51 | MP0000372_irregular_coat_pigmentation | 1.28867750 |
52 | MP0000490_abnormal_crypts_of | 1.28730149 |
53 | MP0002998_abnormal_bone_remodeling | 1.25325285 |
54 | MP0005075_abnormal_melanosome_morpholog | 1.24238587 |
55 | MP0002877_abnormal_melanocyte_morpholog | 1.23597752 |
56 | MP0000703_abnormal_thymus_morphology | 1.23431123 |
57 | MP0000569_abnormal_digit_pigmentation | 1.23378775 |
58 | MP0003191_abnormal_cellular_cholesterol | 1.22566580 |
59 | MP0001873_stomach_inflammation | 1.22320741 |
60 | MP0002933_joint_inflammation | 1.21614775 |
61 | MP0003186_abnormal_redox_activity | 1.17107486 |
62 | MP0009278_abnormal_bone_marrow | 1.16426599 |
63 | MP0003172_abnormal_lysosome_physiology | 1.13120707 |
64 | MP0000015_abnormal_ear_pigmentation | 1.11168967 |
65 | MP0005408_hypopigmentation | 1.10700003 |
66 | MP0000343_altered_response_to | 1.09395874 |
67 | MP0005058_abnormal_lysosome_morphology | 1.08707422 |
68 | MP0004381_abnormal_hair_follicle | 1.08113011 |
69 | MP0003300_gastrointestinal_ulcer | 1.06356367 |
70 | MP0003866_abnormal_defecation | 1.06082847 |
71 | MP0002277_abnormal_respiratory_mucosa | 1.06076986 |
72 | MP0005174_abnormal_tail_pigmentation | 1.02158620 |
73 | MP0000371_diluted_coat_color | 0.96007891 |
74 | MP0010307_abnormal_tumor_latency | 0.95863954 |
75 | MP0008004_abnormal_stomach_pH | 0.94738607 |
76 | MP0009763_increased_sensitivity_to | 0.94420458 |
77 | MP0009840_abnormal_foam_cell | 0.94082923 |
78 | MP0002132_abnormal_respiratory_system | 0.93538657 |
79 | MP0000465_gastrointestinal_hemorrhage | 0.91784621 |
80 | MP0009765_abnormal_xenobiotic_induced | 0.91358579 |
81 | MP0006054_spinal_hemorrhage | 0.90209631 |
82 | MP0008057_abnormal_DNA_replication | 0.90011784 |
83 | MP0002332_abnormal_exercise_endurance | 0.87011654 |
84 | MP0001919_abnormal_reproductive_system | 0.86509582 |
85 | MP0004883_abnormal_blood_vessel | 0.83444261 |
86 | MP0010352_gastrointestinal_tract_polyps | 0.81915455 |
87 | MP0003806_abnormal_nucleotide_metabolis | 0.81442560 |
88 | MP0002163_abnormal_gland_morphology | 0.80360153 |
89 | MP0002693_abnormal_pancreas_physiology | 0.80271051 |
90 | MP0005390_skeleton_phenotype | 0.79122847 |
91 | MP0003786_premature_aging | 0.78347360 |
92 | MP0003646_muscle_fatigue | 0.78085105 |
93 | MP0002019_abnormal_tumor_incidence | 0.77992544 |
94 | MP0005451_abnormal_body_composition | 0.76171766 |
95 | MP0003566_abnormal_cell_adhesion | 0.75454783 |
96 | MP0003453_abnormal_keratinocyte_physiol | 0.75278633 |
97 | MP0005023_abnormal_wound_healing | 0.75203495 |
98 | MP0002254_reproductive_system_inflammat | 0.74129186 |
99 | MP0005389_reproductive_system_phenotype | 0.71531792 |
100 | MP0001851_eye_inflammation | 0.69544436 |
101 | MP0005647_abnormal_sex_gland | 0.69531968 |
102 | MP0005164_abnormal_response_to | 0.68779562 |
103 | MP0005076_abnormal_cell_differentiation | 0.68749223 |
104 | MP0008007_abnormal_cellular_replicative | 0.68651911 |
105 | MP0003075_altered_response_to | 0.67667658 |
106 | MP0005167_abnormal_blood-brain_barrier | 0.66526252 |
107 | MP0000249_abnormal_blood_vessel | 0.65469344 |
108 | MP0005166_decreased_susceptibility_to | 0.65192552 |
109 | MP0004264_abnormal_extraembryonic_tissu | 0.64154248 |
110 | MP0001663_abnormal_digestive_system | 0.63608391 |
111 | MP0003795_abnormal_bone_structure | 0.62899005 |
112 | MP0003828_pulmonary_edema | 0.62732150 |
113 | MP0003091_abnormal_cell_migration | 0.62323171 |
114 | MP0002136_abnormal_kidney_physiology | 0.62017444 |
115 | MP0009115_abnormal_fat_cell | 0.61956749 |
116 | MP0003045_fibrosis | 0.60857884 |
117 | MP0003656_abnormal_erythrocyte_physiolo | 0.60491637 |
118 | MP0001542_abnormal_bone_strength | 0.60103163 |
119 | MP0000767_abnormal_smooth_muscle | 0.58004099 |
120 | MP0001881_abnormal_mammary_gland | 0.57878345 |
121 | MP0004185_abnormal_adipocyte_glucose | 0.57448228 |
122 | MP0000609_abnormal_liver_physiology | 0.55567402 |
123 | MP0003252_abnormal_bile_duct | 0.55535913 |
124 | MP0008873_increased_physiological_sensi | 0.54922729 |
125 | MP0008877_abnormal_DNA_methylation | 0.54664287 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Eczematoid dermatitis (HP:0000976) | 5.27880203 |
2 | Recurrent abscess formation (HP:0002722) | 5.21089923 |
3 | Recurrent bacterial skin infections (HP:0005406) | 4.78566132 |
4 | Autoimmune thrombocytopenia (HP:0001973) | 4.73533784 |
5 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.64903149 |
6 | Mediastinal lymphadenopathy (HP:0100721) | 4.35494919 |
7 | Myositis (HP:0100614) | 4.27333679 |
8 | Increased IgM level (HP:0003496) | 3.94127585 |
9 | Recurrent fungal infections (HP:0002841) | 3.89191404 |
10 | Orchitis (HP:0100796) | 3.88872687 |
11 | Optic neuritis (HP:0100653) | 3.83032094 |
12 | Retrobulbar optic neuritis (HP:0100654) | 3.83032094 |
13 | Vasculitis (HP:0002633) | 3.75641747 |
14 | Recurrent viral infections (HP:0004429) | 3.73697538 |
15 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.67178051 |
16 | Abnormality of T cell number (HP:0011839) | 3.48633411 |
17 | Hematochezia (HP:0002573) | 3.38465421 |
18 | Abnormality of macrophages (HP:0004311) | 3.33256898 |
19 | Stomatitis (HP:0010280) | 3.29895895 |
20 | Recurrent skin infections (HP:0001581) | 3.26822042 |
21 | Chronic otitis media (HP:0000389) | 3.25903292 |
22 | Basal ganglia calcification (HP:0002135) | 3.23645908 |
23 | Meningitis (HP:0001287) | 3.20911505 |
24 | T lymphocytopenia (HP:0005403) | 3.19417651 |
25 | Hypergammaglobulinemia (HP:0010702) | 3.06717860 |
26 | Pustule (HP:0200039) | 2.99313882 |
27 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.98534155 |
28 | Recurrent cutaneous fungal infections (HP:0011370) | 2.98534155 |
29 | Petechiae (HP:0000967) | 2.98136708 |
30 | Abnormality of T cells (HP:0002843) | 2.97933219 |
31 | Periodontitis (HP:0000704) | 2.95116151 |
32 | Eosinophilia (HP:0001880) | 2.93665107 |
33 | Pulmonary infiltrates (HP:0002113) | 2.91254256 |
34 | Autoimmune hemolytic anemia (HP:0001890) | 2.89944952 |
35 | Obstructive lung disease (HP:0006536) | 2.89678110 |
36 | Chronic obstructive pulmonary disease (HP:0006510) | 2.89678110 |
37 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.83867237 |
38 | Gingivitis (HP:0000230) | 2.82972163 |
39 | Abnormality of T cell physiology (HP:0011840) | 2.80891343 |
40 | Cellulitis (HP:0100658) | 2.80256473 |
41 | Recurrent bronchitis (HP:0002837) | 2.76612389 |
42 | Leukocytosis (HP:0001974) | 2.75715075 |
43 | Granulocytopenia (HP:0001913) | 2.72166249 |
44 | Gingival bleeding (HP:0000225) | 2.64000703 |
45 | Poor head control (HP:0002421) | 2.62938729 |
46 | Combined immunodeficiency (HP:0005387) | 2.61871883 |
47 | Keratoconjunctivitis sicca (HP:0001097) | 2.61734234 |
48 | Vacuolated lymphocytes (HP:0001922) | 2.60818702 |
49 | Thrombocytosis (HP:0001894) | 2.60040510 |
50 | Severe combined immunodeficiency (HP:0004430) | 2.59630688 |
51 | Arterial thrombosis (HP:0004420) | 2.57521841 |
52 | IgA deficiency (HP:0002720) | 2.56258666 |
53 | Gastrointestinal infarctions (HP:0005244) | 2.55038418 |
54 | Hemoptysis (HP:0002105) | 2.54441607 |
55 | Abnormality of eosinophils (HP:0001879) | 2.52812967 |
56 | Abnormality of the prostate (HP:0008775) | 2.52733887 |
57 | Prostate neoplasm (HP:0100787) | 2.49208836 |
58 | IgG deficiency (HP:0004315) | 2.48464373 |
59 | Systemic lupus erythematosus (HP:0002725) | 2.47897580 |
60 | IgM deficiency (HP:0002850) | 2.45160198 |
61 | Gangrene (HP:0100758) | 2.44513527 |
62 | Agammaglobulinemia (HP:0004432) | 2.44235231 |
63 | Interstitial pulmonary disease (HP:0006530) | 2.39202390 |
64 | Keratoconjunctivitis (HP:0001096) | 2.38175013 |
65 | Abnormality of the pleura (HP:0002103) | 2.37110124 |
66 | Joint swelling (HP:0001386) | 2.36493640 |
67 | Thyroiditis (HP:0100646) | 2.34987803 |
68 | Epistaxis (HP:0000421) | 2.33001814 |
69 | Recurrent pneumonia (HP:0006532) | 2.32945492 |
70 | Panhypogammaglobulinemia (HP:0003139) | 2.31357468 |
71 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.30261223 |
72 | Osteolytic defects of the hand bones (HP:0009699) | 2.30261223 |
73 | Pulmonary embolism (HP:0002204) | 2.29366306 |
74 | Vertebral compression fractures (HP:0002953) | 2.29110704 |
75 | Encephalitis (HP:0002383) | 2.28994402 |
76 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.28950285 |
77 | Alveolar cell carcinoma (HP:0006519) | 2.28474410 |
78 | Chest pain (HP:0100749) | 2.28437627 |
79 | Osteomyelitis (HP:0002754) | 2.27818291 |
80 | Abnormality of B cell number (HP:0010975) | 2.25695297 |
81 | B lymphocytopenia (HP:0010976) | 2.25695297 |
82 | Prolonged bleeding time (HP:0003010) | 2.24647482 |
83 | Lymphopenia (HP:0001888) | 2.23148514 |
84 | Abnormality of the fingertips (HP:0001211) | 2.22789168 |
85 | Syringomyelia (HP:0003396) | 2.22192377 |
86 | Spinal cord lesions (HP:0100561) | 2.22192377 |
87 | Nasal polyposis (HP:0100582) | 2.21465893 |
88 | Stomach cancer (HP:0012126) | 2.21095881 |
89 | Spontaneous hematomas (HP:0007420) | 2.19201902 |
90 | Recurrent lower respiratory tract infections (HP:0002783) | 2.17229286 |
91 | Lymphoma (HP:0002665) | 2.16701039 |
92 | Hypochromic anemia (HP:0001931) | 2.16698378 |
93 | Neoplasm of the tracheobronchial system (HP:0100552) | 2.16532491 |
94 | Myocardial infarction (HP:0001658) | 2.15043740 |
95 | Chronic diarrhea (HP:0002028) | 2.14818558 |
96 | Porencephaly (HP:0002132) | 2.14451122 |
97 | Tetraparesis (HP:0002273) | 2.12103068 |
98 | Anorexia (HP:0002039) | 2.11681863 |
99 | Verrucae (HP:0200043) | 2.10363595 |
100 | Papilloma (HP:0012740) | 2.10363595 |
101 | Keratitis (HP:0000491) | 2.09232304 |
102 | Urticaria (HP:0001025) | 2.08674466 |
103 | Polyneuropathy (HP:0001271) | 2.08164066 |
104 | Skin ulcer (HP:0200042) | 2.06576123 |
105 | Cheilitis (HP:0100825) | 2.04757424 |
106 | Purpura (HP:0000979) | 2.03904881 |
107 | Amaurosis fugax (HP:0100576) | 2.03160344 |
108 | Reduced antithrombin III activity (HP:0001976) | 2.01981722 |
109 | Inflammation of the large intestine (HP:0002037) | 1.98237198 |
110 | Subacute progressive viral hepatitis (HP:0006572) | 1.97428831 |
111 | Abnormality of the nasal mucosa (HP:0000433) | 1.96942031 |
112 | Microcytic anemia (HP:0001935) | 1.96218914 |
113 | Increased IgE level (HP:0003212) | 1.94322211 |
114 | Hypochromic microcytic anemia (HP:0004840) | 1.93193297 |
115 | Albinism (HP:0001022) | 1.93074706 |
116 | Arthralgia (HP:0002829) | 1.91249952 |
117 | Joint hemorrhage (HP:0005261) | 1.91082680 |
118 | Viral hepatitis (HP:0006562) | 1.87793270 |
119 | Glomerulopathy (HP:0100820) | 1.81963614 |
120 | Prominent nose (HP:0000448) | 1.77787782 |
121 | Pulmonary fibrosis (HP:0002206) | 1.76549431 |
122 | Conjunctival hamartoma (HP:0100780) | 1.76328439 |
123 | Abnormality of male internal genitalia (HP:0000022) | 1.72597299 |
124 | Thrombophlebitis (HP:0004418) | 1.71118055 |
125 | Fair hair (HP:0002286) | 1.70870285 |
126 | Episodic fever (HP:0001954) | 1.68622060 |
127 | Vertigo (HP:0002321) | 1.67861986 |
128 | Mucosal telangiectasiae (HP:0100579) | 1.67205265 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MAP3K14 | 4.86591763 |
2 | TXK | 3.42995517 |
3 | MAP4K1 | 3.16909272 |
4 | JAK3 | 2.97950505 |
5 | TYK2 | 2.91183771 |
6 | IKBKE | 2.88620790 |
7 | TBK1 | 2.86742301 |
8 | IRAK4 | 2.86333718 |
9 | IRAK3 | 2.64022913 |
10 | IKBKB | 2.61311967 |
11 | BLK | 2.18176432 |
12 | PIM2 | 2.13240857 |
13 | PBK | 1.99088301 |
14 | JAK1 | 1.89935894 |
15 | TEC | 1.89733386 |
16 | CHUK | 1.89706061 |
17 | PIM1 | 1.89397144 |
18 | ZAP70 | 1.84757476 |
19 | MST4 | 1.82145455 |
20 | FES | 1.80015488 |
21 | KIT | 1.68502958 |
22 | RIPK4 | 1.59889101 |
23 | STK10 | 1.52447072 |
24 | BTK | 1.51692503 |
25 | BMPR2 | 1.49162484 |
26 | SYK | 1.48093649 |
27 | NME2 | 1.43307691 |
28 | FGFR4 | 1.40582193 |
29 | STK4 | 1.39221178 |
30 | NEK9 | 1.38772540 |
31 | TAOK3 | 1.33474259 |
32 | FGFR3 | 1.32186153 |
33 | CSK | 1.31041302 |
34 | TRPM7 | 1.28863837 |
35 | NLK | 1.26497636 |
36 | ITK | 1.25249564 |
37 | LCK | 1.19742895 |
38 | MAP4K2 | 1.13262124 |
39 | ZAK | 1.13215060 |
40 | ERN1 | 1.11943007 |
41 | PRPF4B | 1.10933976 |
42 | EIF2AK2 | 1.10725666 |
43 | YES1 | 1.07464674 |
44 | GRK7 | 1.06137604 |
45 | LYN | 1.03120420 |
46 | MELK | 1.01778680 |
47 | RPS6KA4 | 1.01262811 |
48 | VRK1 | 1.01207814 |
49 | TRIM28 | 0.99754810 |
50 | SIK3 | 0.99689364 |
51 | JAK2 | 0.99068118 |
52 | TGFBR2 | 0.98442406 |
53 | MAP3K13 | 0.98435335 |
54 | BMPR1B | 0.94730132 |
55 | MARK3 | 0.94484403 |
56 | MAP2K3 | 0.92300103 |
57 | CAMKK2 | 0.89202489 |
58 | CLK1 | 0.87262935 |
59 | * HCK | 0.86512039 |
60 | TLK1 | 0.83490354 |
61 | CSF1R | 0.81906616 |
62 | BRD4 | 0.81394482 |
63 | ERBB3 | 0.80623179 |
64 | BMX | 0.78979191 |
65 | NUAK1 | 0.78952948 |
66 | TAF1 | 0.76621255 |
67 | TNK2 | 0.74190061 |
68 | CDK12 | 0.73149186 |
69 | MAP3K3 | 0.72940036 |
70 | EPHA3 | 0.72200968 |
71 | EIF2AK1 | 0.69294009 |
72 | CDK6 | 0.67353981 |
73 | STK24 | 0.66570250 |
74 | PRKCQ | 0.63565259 |
75 | IRAK1 | 0.62551633 |
76 | EPHB1 | 0.61769826 |
77 | MAP3K1 | 0.60825704 |
78 | MKNK2 | 0.60132287 |
79 | EIF2AK3 | 0.59403722 |
80 | GRK6 | 0.59033443 |
81 | STK3 | 0.58701537 |
82 | ABL1 | 0.57890945 |
83 | ABL2 | 0.57031617 |
84 | MAP2K6 | 0.56627316 |
85 | FLT3 | 0.52892247 |
86 | PRKCD | 0.51343704 |
87 | ACVR1B | 0.51288502 |
88 | LRRK2 | 0.51269601 |
89 | MST1R | 0.51128905 |
90 | MATK | 0.50975248 |
91 | FGR | 0.50953093 |
92 | PTK2B | 0.50488235 |
93 | PIK3CG | 0.49849181 |
94 | RIPK1 | 0.49709596 |
95 | MAP3K5 | 0.48592670 |
96 | RPS6KA6 | 0.48092175 |
97 | TNIK | 0.47160120 |
98 | TGFBR1 | 0.47019842 |
99 | MAPKAPK2 | 0.46836457 |
100 | CDK4 | 0.46612053 |
101 | KDR | 0.44479560 |
102 | MAP3K11 | 0.44242810 |
103 | PIK3CA | 0.44159342 |
104 | GRK1 | 0.41322557 |
105 | RPS6KA5 | 0.40128796 |
106 | AKT3 | 0.39383873 |
107 | PASK | 0.38901759 |
108 | PLK4 | 0.38634842 |
109 | SMG1 | 0.38314398 |
110 | PRKG2 | 0.37018171 |
111 | PDK1 | 0.36392995 |
112 | RPS6KC1 | 0.35445858 |
113 | RPS6KL1 | 0.35445858 |
114 | GRK5 | 0.35267195 |
115 | HIPK2 | 0.34448797 |
116 | PLK3 | 0.34110988 |
117 | ATR | 0.32647626 |
118 | MAP3K10 | 0.31790655 |
119 | MAPK7 | 0.31698330 |
120 | FRK | 0.29522569 |
121 | MAPK3 | 0.29462367 |
122 | MAPK4 | 0.29193224 |
123 | MAP3K2 | 0.29166561 |
124 | TESK1 | 0.28683535 |
125 | IRAK2 | 0.27601235 |
126 | ADRBK1 | 0.27415854 |
127 | MAPKAPK3 | 0.27168147 |
128 | EGFR | 0.26285561 |
129 | RPS6KB2 | 0.25692853 |
130 | MAPK11 | 0.24462160 |
131 | ADRBK2 | 0.23542767 |
132 | IGF1R | 0.22785709 |
133 | TAOK2 | 0.22460578 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.27172851 |
2 | Allograft rejection_Homo sapiens_hsa05330 | 3.15487529 |
3 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.91937211 |
4 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.79342894 |
5 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.74276927 |
6 | Leishmaniasis_Homo sapiens_hsa05140 | 2.69001125 |
7 | Measles_Homo sapiens_hsa05162 | 2.60129733 |
8 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.51925354 |
9 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.45197570 |
10 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.39126523 |
11 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.35651475 |
12 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.07249187 |
13 | Herpes simplex infection_Homo sapiens_hsa05168 | 2.02373840 |
14 | Legionellosis_Homo sapiens_hsa05134 | 2.00758739 |
15 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.91771153 |
16 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.89729288 |
17 | Influenza A_Homo sapiens_hsa05164 | 1.88797779 |
18 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.84325870 |
19 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.78683815 |
20 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.76471053 |
21 | Malaria_Homo sapiens_hsa05144 | 1.75894583 |
22 | Asthma_Homo sapiens_hsa05310 | 1.70195114 |
23 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.68906715 |
24 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.66932860 |
25 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.66116157 |
26 | Pertussis_Homo sapiens_hsa05133 | 1.59216042 |
27 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.56288876 |
28 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.52180338 |
29 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.49100568 |
30 | Tuberculosis_Homo sapiens_hsa05152 | 1.46449335 |
31 | Apoptosis_Homo sapiens_hsa04210 | 1.45169168 |
32 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.39631434 |
33 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.38748342 |
34 | Viral myocarditis_Homo sapiens_hsa05416 | 1.26494559 |
35 | Hepatitis B_Homo sapiens_hsa05161 | 1.24986165 |
36 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.23649646 |
37 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.21589997 |
38 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.21314100 |
39 | Salmonella infection_Homo sapiens_hsa05132 | 1.12768489 |
40 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.12656194 |
41 | Shigellosis_Homo sapiens_hsa05131 | 1.12569792 |
42 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.10981960 |
43 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.10502858 |
44 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.10244982 |
45 | Hepatitis C_Homo sapiens_hsa05160 | 1.05219843 |
46 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.95311583 |
47 | Other glycan degradation_Homo sapiens_hsa00511 | 0.94655368 |
48 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.90504943 |
49 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.90309618 |
50 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.88804778 |
51 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.86135610 |
52 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.84077774 |
53 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.82703058 |
54 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.82477717 |
55 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.81301818 |
56 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.79896214 |
57 | DNA replication_Homo sapiens_hsa03030 | 0.78773053 |
58 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.78407356 |
59 | Lysosome_Homo sapiens_hsa04142 | 0.74594149 |
60 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.74404848 |
61 | Phagosome_Homo sapiens_hsa04145 | 0.73040968 |
62 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.71970111 |
63 | Base excision repair_Homo sapiens_hsa03410 | 0.70810429 |
64 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.70590634 |
65 | Proteasome_Homo sapiens_hsa03050 | 0.70313335 |
66 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.67474989 |
67 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.66015351 |
68 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.64776809 |
69 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.61666515 |
70 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.59153584 |
71 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.58083361 |
72 | HTLV-I infection_Homo sapiens_hsa05166 | 0.55147986 |
73 | Platelet activation_Homo sapiens_hsa04611 | 0.51129579 |
74 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.50893036 |
75 | Basal transcription factors_Homo sapiens_hsa03022 | 0.50714636 |
76 | Insulin resistance_Homo sapiens_hsa04931 | 0.50679757 |
77 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.50587326 |
78 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.50133450 |
79 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.48139037 |
80 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.47263852 |
81 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.45569818 |
82 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.45508313 |
83 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.45452491 |
84 | Homologous recombination_Homo sapiens_hsa03440 | 0.45093425 |
85 | Mismatch repair_Homo sapiens_hsa03430 | 0.43488887 |
86 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.43235918 |
87 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.42052662 |
88 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.39800160 |
89 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.36936627 |
90 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.36403894 |
91 | Amoebiasis_Homo sapiens_hsa05146 | 0.36160402 |
92 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.34509937 |
93 | Prostate cancer_Homo sapiens_hsa05215 | 0.33779359 |
94 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.33666053 |
95 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.33503708 |
96 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.33381632 |
97 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.33026435 |
98 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.32236918 |
99 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.31986626 |
100 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.31713503 |
101 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.30859405 |
102 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.30461385 |
103 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.30445064 |
104 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.29713401 |
105 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.29467381 |
106 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.29356605 |
107 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.29343339 |
108 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.28148585 |
109 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.27017977 |
110 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.25605180 |
111 | Galactose metabolism_Homo sapiens_hsa00052 | 0.22930093 |
112 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.22812709 |
113 | RNA degradation_Homo sapiens_hsa03018 | 0.22809828 |
114 | Thyroid cancer_Homo sapiens_hsa05216 | 0.21870801 |
115 | Protein export_Homo sapiens_hsa03060 | 0.21458243 |
116 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.20961281 |
117 | ABC transporters_Homo sapiens_hsa02010 | 0.20676894 |
118 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.19896455 |
119 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.19872883 |
120 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.19793918 |
121 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.19059215 |
122 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.17182174 |
123 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.16411394 |
124 | Colorectal cancer_Homo sapiens_hsa05210 | 0.16218708 |